131 - Challenging Cases in Transplant ID

Saturday, October 2, 2021

1:15 PM - 3:00 PM EDT

Interactive Moderator(s)

Pearlie Chong, MD, MSCR

Assistant Professor of Medicine
University of Texas Southwestern
Dallas, TX, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Steven Pergam, MD, MPH

Associate Professor
Fred Hutchinson Cancer Research Center; University of Washington
Seattle, WA, United States

Chimerix (Individual(s) Involved: Self): Clinical Trial; Global Life Technologies, Inc (Individual(s) Involved: Self): Research Grant or Support; Merck & Co. (Individual(s) Involved: Self): Scientific Research Study Investigator; Sanofi Aventis (Individual(s) Involved: Self): Other Financial or Material Support, Provided vaccines for clinical trial sponsored by the NIH

Panelist(s)

Fernanda Silveira, MD, MS, FIDSA

Associate Professor of Medicine
University of Pittsburgh
Pittsburgh, PA, United States

Ansun (Individual(s) Involved: Self): Grant/Research Support; Novartis (Individual(s) Involved: Self): Grant/Research Support; Qiagen (Individual(s) Involved: Self): Grant/Research Support; Shire (Individual(s) Involved: Self): Advisor or Review Panel member, Grant/Research Support; SlieaGen (Individual(s) Involved: Self): Grant/Research Support; Whiscon (Individual(s) Involved: Self): Grant/Research Support
Jennifer Saullo, MD, Pharm D

Assistant Professor
Department of Medicine, Division of Infectious Diseases
Duke University
Durham, NC, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Upton Allen, MD

Chief, Division of Infectious Diseases
Hosp Sick Children
Toronto, ON, Canada

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Pearlie P. Chong, MD, MSCR: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Steven A. Pergam, MD, MPH: Chimerix (Individual(s) Involved: Self): Clinical Trial; Global Life Technologies, Inc (Individual(s) Involved: Self): Research Grant or Support; Merck & Co. (Individual(s) Involved: Self): Scientific Research Study Investigator; Sanofi Aventis (Individual(s) Involved: Self): Other Financial or Material Support, Provided vaccines for clinical trial sponsored by the NIH

Fernanda P. Silveira, MD, MS, FIDSA: Ansun (Individual(s) Involved: Self): Grant/Research Support; Novartis (Individual(s) Involved: Self): Grant/Research Support; Qiagen (Individual(s) Involved: Self): Grant/Research Support; Shire (Individual(s) Involved: Self): Advisor or Review Panel member, Grant/Research Support; SlieaGen (Individual(s) Involved: Self): Grant/Research Support; Whiscon (Individual(s) Involved: Self): Grant/Research Support

Jennifer Saullo, MD, Pharm D: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Upton D. Allen, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
ACPE Credits: ACPE 1.75 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss approach to work up of a complicated transplant patient
review common and uncommon pathogens seen in transplant
restate important steps in the diagnostic approach to a transplant patients with new infectious symptoms